Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.58 |
| ▸ | ECE1 | P42892 | 13/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | MPO | P05164 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.52 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31171651 | 0.93 | ACE (0.59) | ACEECE1KDM4EMEN1LMNA | |
| SCHEMBL30123058 | 0.92 | ACE (0.63) | ACEECE1 | |
| SCHEMBL30050967 | 0.92 | ACE (0.68) | ACEECE1KDM4EMEN1LMNA | |
| SCHEMBL21641800 | 0.92 | KDM4E (0.65) | ACEECE1KDM4EMEN1LMNA | |
| SCHEMBL21641799 | 0.92 | KDM4E (0.65) | ACEECE1KDM4EMEN1LMNA | |
| SCHEMBL29581685 | 0.92 | KDM4E (0.65) | ACEECE1KDM4EMEN1LMNA | |
| SCHEMBL30093080 | 0.90 | ACE (0.66) | ACEECE1KDM4EMEN1LMNA | |
| SCHEMBL30093097 | 0.90 | ACE (0.66) | ACEECE1KDM4EMEN1LMNA | |
| SCHEMBL30053206 | 0.89 | ACE (0.61) | ACEECE1KDM4EMEN1LMNA | |
| SCHEMBL30051713 | 0.89 | ECE1 (0.63) | ACEECE1KDM4EMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1259 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114080232-B | Extracellular vesicles for vaccine delivery | Lhasa Sales Co.,Ltd. (CH) | 2026-05-26 | — | — | CN | disclosed |
| CN-113881680-B | T cell antigen receptor, multimeric complex thereof, and preparation method and application thereof | 华夏英泰（北京）生物技术有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-115433273-B | Anti-novel coronavirus rabbit recombinant monoclonal antibody with neutralization activity and application thereof | 苏州缔码生物科技有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-117285644-B | Phase change regulating element and application thereof | 清华大学 | 2026-05-15 | — | — | CN | disclosed |
| CN-116583298-B | PD-1 targeted IL-15/IL-15RαFC fusion proteins with improved properties | 基因泰克公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-112261874-B | Inhibition of fungal growth by manganese depletion | 科·汉森有限公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-115851648-B | Glycerol glucoside phosphorylase mutant with improved thermal stability and catalytic activity and application thereof | 中国科学院天津工业生物技术研究所 | 2025-06-10 | — | — | CN | disclosed |
| CN-114230670-B | Chimeric Antigen Receptor (CAR) targeting hematological malignancies, compositions and methods of use thereof | 美商生物细胞基因治疗有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-112912400-B | NK adaptor molecules and methods of use thereof | 明尼苏达大学董事会 | 2025-05-30 | — | — | CN | disclosed |
| CN-112672760-B | Novel LILRB4 antibodies and uses thereof | 德克萨斯大学体系董事会 | 2025-05-30 | — | — | CN | disclosed |
| CN-109393138-B | Chicken taste-presenting peptide and preparation method and application thereof | 天津春发生物科技集团有限公司 | 2022-02-15 | — | — | CN | disclosed |
| CN-107208088-B | Oleic acid production in yeast | 银杏生物制品公司 | 2022-02-11 | — | — | CN | disclosed |
| CN-107002047-B | Pestivirus | 英特维特国际股份有限公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-107427574-B | CXCR4 binding molecules | 阿达尔塔有限公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-114026116-A | RAS neoantigen specific binding proteins and uses thereof | 弗雷德哈钦森癌症研究中心 | 2022-02-08 | — | — | CN | disclosed |
| CN-114008069-A | Compositions of exosomes and AAV | 科迪亚克生物科学公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-111836827-B | Multispecific chimeric receptors comprising NKG2D domains and methods of use thereof | 南京传奇生物科技有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-113993989-A | Process for producing ergothioneine | 丹麦科技大学 | 2022-01-28 | — | — | CN | disclosed |
| CN-113993550-A | Conditioning method for gene therapy | 美真达治疗公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-113980931-A | Application of glucuronic acid hydrolase and mutant thereof in preparation of oleanolic acid-beta-D-glucopyranosyl ester | 上海中医药大学 | 2022-01-28 | — | — | CN | disclosed |